UBS analyst Brian Meredith raised the firm’s price target on Brown & Brown to $94 from $91 and keeps a Neutral rating on the shares. The macro environment continues to support good fundamentals for the life insurers and the firm expects P&C earnings to reflect strong fundamentals with some caution in results from uncertain “tort” inflation, the analyst tells investors in a set of preview notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRO:
- Brown & Brown, Inc. announces 2024 second-quarter earnings release and conference call dates
- Brown & Brown acquires assets of McNamara Company, no terms
- Brown & Brown, Inc. acquires the assets of McNamara Company
- Brown & Brown price target raised to $100 from $94 at Citi
- Brown & Brown upgraded to Neutral from Underperform at BofA